Used in pharmaceutical research as a chiral intermediate for synthesizing protease inhibitors, particularly in the development of drugs targeting viral enzymes such as those in hepatitis C and HIV. Its structural features support high selectivity and binding affinity in enzyme inhibition. Also employed in asymmetric synthesis due to the chiral center, enabling the production of enantiomerically pure compounds. Commonly found in studies focused on optimizing pharmacokinetic properties of peptide-like therapeutics.